Regulatory data is for reference only. Always verify with the official regulator before making formulation decisions. Last refreshed: 10/13/2026.
Ingredients/Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine
Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholineCAS 1593-77-7
EU CosIng II — prohibitedASEAN II — prohibitedUK OPSS — prohibited
Is Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine restricted in cosmetics?
Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine is prohibited in EU CosIng, ASEAN and UK OPSS. Markets not named here hold no entry for it, which is not a clearance.
- CAS
- 1593-77-7
- INCI
- Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine
- Data refreshed
- 2026-10-13
Regulatory status
What this means
Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine has regulatory signals in EU CosIng, ASEAN, UK OPSS. Review the source links above for the official conditions and latest updates.
Recent regulatory changes
No recorded regulatory changes for Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine yet.
Common questions
- Is Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine restricted in EU cosmetics?
- Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine is prohibited in EU cosmetics according to EU CosIng Annex II.
- Is Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine restricted under the ASEAN Cosmetic Directive?
- Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine is prohibited under the ASEAN Cosmetic Directive Annex II.
- Is Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine restricted in UK OPSS?
- Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine is prohibited in cosmetics under UK OPSS.
- What is the CAS number for Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine?
- The CAS number for Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine is 1593-77-7.
Check this ingredient in a formula across 11 markets
This page covers one ingredient on its own. Sign up free to check it at your actual concentration, in a full formula, with GHS hazards and per-market verdicts.